Anti-NALF2/ FAM155B/ CXorf63 monoclonal antibody

Anti-NALF2/ FAM155B/ CXorf63 antibody for FACS & in-vivo assay

Target products collectionGo to FAM155B/FAM155B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0430-Ab-1/ GM-Tg-hg-MP0430-Ab-2Anti-Human FAM155B monoclonal antibodyHuman
GM-Tg-rg-MP0430-Ab-1/ GM-Tg-rg-MP0430-Ab-2Anti-Rat FAM155B monoclonal antibodyRat
GM-Tg-mg-MP0430-Ab-1/ GM-Tg-mg-MP0430-Ab-2Anti-Mouse FAM155B monoclonal antibodyMouse
GM-Tg-cynog-MP0430-Ab-1/ GM-Tg-cynog-MP0430-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM155B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0430-Ab-1/ GM-Tg-felg-MP0430-Ab-2Anti-Feline FAM155B monoclonal antibodyFeline
GM-Tg-cang-MP0430-Ab-1/ GM-Tg-cang-MP0430-Ab-2Anti-Canine FAM155B monoclonal antibodyCanine
GM-Tg-bovg-MP0430-Ab-1/ GM-Tg-bovg-MP0430-Ab-2Anti-Bovine FAM155B monoclonal antibodyBovine
GM-Tg-equg-MP0430-Ab-1/ GM-Tg-equg-MP0430-Ab-2Anti-Equine FAM155B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0430-Ab-1/ GM-Tg-hg-MP0430-Ab-2; GM-Tg-rg-MP0430-Ab-1/ GM-Tg-rg-MP0430-Ab-2;
GM-Tg-mg-MP0430-Ab-1/ GM-Tg-mg-MP0430-Ab-2; GM-Tg-cynog-MP0430-Ab-1/ GM-Tg-cynog-MP0430-Ab-2;
GM-Tg-felg-MP0430-Ab-1/ GM-Tg-felg-MP0430-Ab-2; GM-Tg-cang-MP0430-Ab-1/ GM-Tg-cang-MP0430-Ab-2;
GM-Tg-bovg-MP0430-Ab-1/ GM-Tg-bovg-MP0430-Ab-2; GM-Tg-equg-MP0430-Ab-1/ GM-Tg-equg-MP0430-Ab-2
Products NameAnti-FAM155B monoclonal antibody
Formatmab
Target NameFAM155B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FAM155B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NALF2/ FAM155B/ CXorf63 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0430
    Target NameFAM155B
    Gene ID27112,620592,688841,695830,607468,101086120,613918,100066446
    Gene Symbol and SynonymsbB57D9.1,CXorf63,EG620592,FAM155B,NALF2,TED,™EM28,Tmem28l,Tnen28
    Uniprot AccessionO75949
    Uniprot Entry NameNALF2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130054
    Target ClassificationN/A

    The target: FAM155B, gene name: FAM155B, also named as CXorf63, TED, ™EM28, bB57D9.1. This gene encodes a product belonging to a family of proteins with unknown function. The presence of two transmembrane domains suggests that this protein is a multi-pass membrane protein. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.